Candida speciation, antifungal treatment and adverse events in pediatric invasive candidiasis: Results from 441 infections in a prospective, multi-national study

Debra L. Palazzi, Antonio Arrieta, Elio Castagnola, Natasha Halasa, Sydney Hubbard, Ava A. Brozovich, Brian T. Fisher, William J. Steinbach

Research output: Contribution to journalArticle


A multi-national prospective study of pediatric patients with invasive candidiasis between August 2007 and September 2012 was performed and included 441 infections. Variation in infecting Candida species and antifungals used was noted between US and non-US sites. Antifungalassociated adverse events were most common with polyene use.

Original languageEnglish
Pages (from-to)1294-1296
Number of pages3
JournalPediatric Infectious Disease Journal
Issue number12
Publication statusPublished - 2014



  • Adverse events
  • Antifungal
  • Fungal
  • Invasive candidiasis
  • Pediatric

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases
  • Microbiology (medical)
  • Medicine(all)

Cite this